文献速递生殖医学产科

单胎妊娠中胚胎植入前非整倍体遗传学检测与不良产科及新生儿结局无关

Preimplantation genetic testing for aneuploidy is not related to adverse obstetric and neonatal outcomes in singleton pregnancies.
PubMed 文献 · Hum Reprod · 2023-01-01

多中心回顾性队列研究纳入2016年10月至2021年1月间IVF/ICSI后单胎活产7146例,其中接受PGT-A者3296例、未接受者3850例。单因素分析显示PGT-A组子痫前期、剖宫产和低Apgar评分发生率较高,但校正混杂因素后PGT-A与不良产科及新生儿结局增加无关。NGS筛查亚组中PGT-A组早产风险降低。

要点

  • 校正混杂因素后,PGT-A与子痫前期等不良产科及新生儿结局增加无关。
  • 单因素分析中PGT-A组子痫前期、剖宫产和低Apgar评分发生率较高。
  • NGS筛查亚组中,PGT-A组早产风险降低。

核心结论

  • PGT-A与IVF/ICSI后单胎妊娠的不良母儿结局发生率增加无关。
  • 当前研究未显示PGT-A后出现任何主要不良临床结局。

研究设计与样本

  • 多中心回顾性队列研究,在大学附属不孕症中心开展。
  • 纳入2016年10月至2021年1月间IVF/ICSI后单胎活产,共7146例;接受PGT-A者3296例,未接受者3850例。
  • 亚组分析仅纳入经下一代测序(NGS)筛查的囊胚。

主要发现

  • 单因素分析显示,PGT-A组子痫前期、剖宫产发生率及低Apgar评分高于未行PGT-A组。
  • 采用多因素logistic和线性回归模型校正众多可能混杂因素后,接受胚胎活检的妊娠未增加不良产科及新生儿结局。
  • NGS筛查囊胚的亚组分析显示,PGT-A组早产风险降低。

局限性

  • 因研究主要为回顾性设计等局限性,解读数据时应谨慎。
  • 尽管为大型多中心研究,数据采集包括自报问卷,且分娩发生于采用不同方案的不同机构。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the potential impact of preimplantation genetic testing for aneuploidy (PGT-A) on obstetric and neonatal outcomes? SUMMARY ANSWER: PGT-A is not associated with increased rates of adverse maternal and neonatal outcomes in singleton pregnancies following IVF/ICSI cycles. WHAT IS KNOWN ALREADY: PGT-A pregnancies may be associated with increased risks of lower birthweight, preterm delivery, and hypertensive disorders compared with natural pregnancies. In a recent meta-analysis, the overall obstetric and neonatal outcomes of PGT-A pregnancies were favorable compared with those of IVF/ICSI pregnancies, although PGT-A pregnancies were associated with a higher risk of hypertensive disorders. STUDY DESIGN, SIZE, DURATION: A multicenter retrospective cohort study was performed in University-affiliated infertility centers. Single live births following IVF/ICSI between October 2016 and January 2021 were included in the study. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 7146 live births after single embryo transfers with (n = 3296) or without (n = 3850) PGT-A were included. The primary outcome was pre-eclampsia and secondary outcomes included gestational diabetes, low birthweight and very low birthweight, cesarean section delivery, emergency cesarean section, as well as preterm birth, birthweight, congenital abnormalities, neonatal sex, Apgar score at 5 min, and neonatal intensive care unit admission. In a subgroup analysis, were included only blastocysts screened with next-generation sequencing (NGS). MAIN RESULTS AND THE ROLE OF CHANCE: Univariate analysis showed that pre-eclampsia, cesarean section incidence, and low Apgar score were higher in women undergoing PGT-A. However, after performing multivariate logistic and linear regression models accounting for many possible confounders, pregnancies that had been conceived after embryo biopsy showed no increase in adverse obstetric and neonatal outcomes. The subgroup analysis including patients with blastocysts screened by NGS showed a decreased risk of preterm birth in the group undergoing PGT-A. LIMITATIONS, REASONS FOR CAUTION: Caution should be used when interpreting the data because of its limitations, mainly related to its retrospective design. Although this is a large multicenter study, data acquisition included self-reporting questionnaires, and the deliveries occurred in different institutions with distinct protocols. WIDER IMPLICATIONS OF THE FINDINGS: The current study does not show any major adverse clinical outcomes after PGT-A. Efforts should be made to promote good quality research on embryo biopsy in terms of neonatal and obstetric outcomes, as well as its long-term consequences. STUDY FUNDING/COMPETING INTEREST(S): No specific funding was obtained for this study. The authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Cozzolino M, Cecchino GN, Garcia Velasco JA, et al. Preimplantation genetic testing for aneuploidy is not related to adverse obstetric and neonatal outcomes in singleton pregnancies. Hum Reprod. 2023. PMID: 37336546. doi:10.1093/humrep/dead123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。